L

Life Science REIT PLC
LSE:LABS

Watchlist Manager
Life Science REIT PLC
LSE:LABS
Watchlist
Price: 43.1 GBX Market Closed
Market Cap: £150.9m

Life Science REIT PLC
Cash from Financing Activities

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Life Science REIT PLC
Cash from Financing Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
L
Life Science REIT PLC
LSE:LABS
Cash from Financing Activities
-£5.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Primary Health Properties PLC
LSE:PHP
Cash from Financing Activities
£301m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Assura PLC
LSE:AGR
Cash from Financing Activities
£196.3m
CAGR 3-Years
-21%
CAGR 5-Years
14%
CAGR 10-Years
N/A
Target Healthcare REIT PLC
LSE:THRL
Cash from Financing Activities
-£82.3m
CAGR 3-Years
-49%
CAGR 5-Years
-66%
CAGR 10-Years
N/A
No Stocks Found

Life Science REIT PLC
Glance View

Market Cap
150.9m GBX
Industry
Real Estate

Life Science Reit Plc is an investment company, which intends to carry on business as a REIT. The Company’s investment objective is to provide shareholders with a level of total return. The company will seek to achieve its investment objective by investing in a diversified portfolio of properties across the United Kingdom which are leased or intended to be leased to tenants operating in, or providing a benefit to, the life science sector. The company acquires or develops properties, such as wet and dry laboratories, offices, incubators and co-working space, manufacturing and testing facilities and data centers. The company acquires individual buildings, a group of buildings across a single science park or the entirety of a science park. This may include purchasing or developing buildings that are leased or intended to be leased to tenants providing ancillary services to employees of companies operating in, or providing a benefit to, the life science sector. The Company’s investment adviser is Ironstone Asset Management Limited.

LABS Intrinsic Value
29.63 GBX
Overvaluation 31%
Intrinsic Value
Price GBX43.1
L

See Also

What is Life Science REIT PLC's Cash from Financing Activities?
Cash from Financing Activities
-5.3m GBP

Based on the financial report for Dec 31, 2024, Life Science REIT PLC's Cash from Financing Activities amounts to -5.3m GBP.

What is Life Science REIT PLC's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 1Y
80%

Over the last year, the Cash from Financing Activities growth was 80%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett